Transfusion practices in human immunodeficiency virus‐infected patients

Transfusion

Volumn 35, Issue 7, 1995, Pages 612-616

  Popovsky, M A ^a,c   Glassman, A B ^b   Hume, H ^b   Oberman, H A ^b   Pisciotto, P T ^b   Anderson, K C ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b American Red Cross Blood Services ^*

^c AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ERYTHROPOIETIN; ZIDOVUDINE;

ALLOIMMUNITY; ARTICLE; BLOOD BANK; BLOOD TRANSFUSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOMODULATION; PRACTICE GUIDELINE; SERODIAGNOSIS; THROMBOCYTOPENIA; VIRUS ACTIVATION;

BLOOD TRANSFUSION; HIV INFECTIONS; HUMAN;

EID: 0029143704     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1995.35795357887.x     Document Type: Article

References (35)

1. Lymphocyte response to blood transfusion in man
2. Increase in the number of lymphocytes secreting IgG following blood transfusion
3. Immunologic abnormalities in patients receiving multiple blood transfusions
4. The effect of previous blood transfusion on lymphocyte subsets and natural killer cell function in patients with colorectal cancer
5. Transfusion and recipient immune function
6. Transfusion‐induced immunomodulation and its clinical consequences
7. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery
8. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery
9. Postoperative infections following autologous and homologous blood transfusions
10. Infection or suspected infection after hip replacement with autologous or homologous blood transfusions
11. Perioperative allogeneic blood transfusions: survival in patients with resected carcinomas of the colon and rectum
12. Increased recurrence rates in perioperatively transfused colorectal malignancy patients
13. Relation between recurrence of cancer of the colon and blood transfusion
14. Adverse relationship between blood transfusions and survival after colectomy for colon cancer
15. Blood transfusions and prognosis in colorectal cancer
16. Blood transfusion and postoperative infection in orthopedic patients
17. Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection
18. Allogeneic leukocytes but not therapeutic blood elements induce reactivation and dissemination of latent human immunodeficiency virus type 1 infection: implications for transfusion support of infected patients
19. Effect of blood transfusions on subsequent kidney transplants
20. The beneficial effect of pretransplant blood transfusions in cyclosporine‐treated cadaver renal allograft recipients
21. Immunologic effects of blood transfusion upon renal transplantation, tumor operations and bacterial infections
22. Early transfusion and length of survival in acquired immune deficiency syndrome: experience with a population receiving medical care at a public hospital
23. Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion
24. Wolf in wolf's clothing: is it time to raise the bounty on the passenger leukocyte? (editorial)
25. Bedside filtration of blood products in the prevention of HLA alloimmunization—a prospective randomized study
26. Passenger leukocytes, cytokines, and transfusion reactions (editorial)
27. Consistency of pre‐storage leukocyte removal (abstract)
28. Evaluation of a new RBC leukodepletion filter designed for in‐laboratory use (abstract)
29. Prevention of transfusion‐acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group
30. Prevention of primary cytomegalovirus infection in patients with hematologic white cell depletion of blood products
31. Prevention of transfusion‐associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood
32. Comparison of filtered blood (FB) to seronegative blood products (SB) for prevention of cytomegalovirus (CMV) infection after marrow transplant (abstract)
33. Variation in blood component irradiation practice: implications for prevention of transfusion‐associated graft‐versus‐host disease
34. Participation of HIV‐infected patients in autologous blood programs
35. HIV‐infected patients participating in autologous blood programs (letter)